Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Amarin Corporation plc (AMRN)

19.87   2.44 (14%) 02-22 16:00
Open: 17.65 Pre. Close: 17.43
High: 20.5 Low: 17.6
Volume: 28,643,625 Market Cap: 6416M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 20.519 - 20.598 20.598 - 20.689
Low: 17.411 - 17.486 17.486 - 17.571
Close: 19.715 - 19.849 19.849 - 20.003

Technical analysis

as of: 2019-02-22 4:39:53 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 23.94     One year: 27.97
Support: Support1: 17.50    Support2: 15.65
Resistance: Resistance1: 20.50    Resistance2: 23.94
Pivot: 17.15
Moving Average: MA(5): 17.94     MA(20): 17.12
MA(100): 17.63     MA(250): 9.05
MACD: MACD(12,26): 0.49     Signal(9): 0.31
Stochastic oscillator: %K(14,3): 69.96     %D(3): 68.09
RSI: RSI(14): 69.25
52-week: High: 23.34  Low: 2.35  Change(%): 437.0
Average Vol(K): 3-Month: 788613  10-Days: 682173

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
AMRN has closed above the upper band by 26.4%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 48.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to AMRN's normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2019-02-22T18:18:00-05:00
AMARIN CORPORATION INVESTOR ALERT: Gibbs Law Group Files Class Action Lawsuit Alleging Violations of Federal Securities Laws

2019-02-20T06:14:45-05:00
Amarin: Vascepa's Strong Growth Reflects The Positive Reactions From Doctors To REDUCE-IT

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 326.29
Shares Float (M) 323.32
% Held by Insiders
% Held by Institutions 52.60
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.360
EPS Est. Current Year -0.210
EPS Est. Next Year -0.060
EPS Est. Next Quarter -0.030
Forward EPS -0.020
Book Value (p.s.) 49030.809
PEG Ratio -2.49
Profit Margin -54.50
Operating Margin -40.63
Return on Assets (ttm) -56.1
Return on Equity (ttm) 145.7
Qtrly Rev. Growth 16.8
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -64.54
Levered Free Cash Flow (M) -38.59

Stock Valuations

P/E -55.19
P/E Growth Ratio 0.14
P/BV
P/S 8911694848.00
P/CF -100.45

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.